Amarin Corp Plcuk (AMRN) Interest Coverage Ratio (2015 - 2017)
Amarin Corp Plcuk (AMRN) reported Interest Coverage Ratio of 3711.0 for Q1 2017, down 1843.6% year-over-year from 212.83 in Q1 2016, and down 201417.84% quarter-over-quarter from 1.84 in Q4 2016.
Amarin Corp Plcuk (AMRN) Interest Coverage Ratio (2015 - 2017) Analysis & Trends
Amarin Corp Plcuk (AMRN) has 3 years of Interest Coverage Ratio data on file, last reported at 3711.0 in Q1 2017.
- Interest Coverage Ratio for Q1 2017 came in at 3711.0, down 1843.6% year-over-year; the trailing twelve-month figure through Dec 2017 was 9111.0 (down 884967.2% YoY), and the FY2025 annual result was 1287.43, up 53.31% from the prior year.
- Interest Coverage Ratio slipped to 3711.0 in Q1 2017 per AMRN's latest filing, from 1.84 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 1.84 in Q4 2016 and troughed at 3711.0 in Q1 2017.
- A 3-year average of 651.59 and a median of 195.74 in 2016 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2016 and 2017: Interest Coverage Ratio jumped 298.42% in 2016, then tumbled 1843.6% in 2017.
- A 3-year view of Interest Coverage Ratio shows it stood at 0.93 in 2015, then jumped by 298.42% to 1.84 in 2016, then tumbled by 201417.84% to 3711.0 in 2017.
- Business Quant data shows AMRN's Interest Coverage Ratio at 3711.0 in Q1 2017, 1.84 in Q4 2016, and 195.74 in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -13.73 |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 23.39 |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | - |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | - |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 4.06 |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 10.78 |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | - |
| 10 | Amarin Corp Plcuk | 6.77 Bn | 6.59 Bn | 17.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | -3,711.00 |
| Dec 31, 2016 | 1.84 |
| Sep 30, 2016 | -195.74 |
| Mar 31, 2016 | -190.93 |
| Dec 31, 2015 | -0.93 |
| Sep 30, 2015 | -253.08 |
| Mar 31, 2015 | -211.32 |